Helen E. Bryant

10.9k citations

69 papers · 8.0k indexed · 2 hit papers · h-index 32

Impact in

Oncology top 0.2%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Molecular Biology top 1%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Cancer therapeutics and mechanisms
- Cell death mechanisms and regulation

Papers in

Oncology 33
- PARP inhibition in cancer therapy 21
Cancer Research 11

Co-authors: Thomas Helleday Niklas Schultz Mark Meuth Nicola J. Curtin Huw D. Thomas Elena López‐Knowles Suzanne Kyle Luke K. McKenzie
Journals: Oncotarget (5 papers)DNA repair (4 papers)Journal of Biological Chemistry (3 papers)Nucleic Acids Research (3 papers)Journal of Virology (3 papers)
Partner nations: United Kingdom Sweden United States

In The Last Decade

Helen E. Bryant

67 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

Transition metal complexes as photosensitisers in one- and two-photon photodynamic therapy 2018 · 356 citations

Peers

Countries citing papers authored by Helen E. Bryant

Since Specialization

Citations

This map shows the geographic impact of Helen E. Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Bryant more than expected).

Fields of papers citing papers by Helen E. Bryant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen E. Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Bryant. The network helps show where Helen E. Bryant may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Helen E. Bryant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helen E. Bryant Line = papers co-authored together Helen E. Bryant links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better Journal of Nuclear Medicine ·Peter J. Gawne, Helen E. Bryant, Steven G. DuBois, Sally L. George, Juliet C. Gray, José Nunes Silva Filho, Kyle B. Matchett, 唐德金, Katherine A. Vallis, H. James Wallace, Simon Wan, Mark N. Gaze	2025	1
2	Phototoxicity of cyclometallated Ir(III) complexes bearing a thio-bis-benzimidazole ligand, and its monodentate analogue, as potential PDT photosensitisers in cancer cell killing JBIC Journal of Biological Inorganic Chemistry ·Marta Martı́nez-Alonso, Dang Chun-bo, Marlen S. Lapson, Dimitri Chekulaev, Helen E. Bryant, Julia A. Weinstein	2024	12
3	Targeting OGG1 and PARG radiosensitises head and neck cancer cells to high-LET protons through complex DNA damage persistence Cell Death and Disease ·Maria Rita Fabbrizi, Justine Ursula Brehm Cripps, Jonathan R. Hughes, Emily A. Robinson, R W Allchin, Carlos P. Rubbi, Andrzej Kacperek, Helen E. Bryant, Thomas Helleday, Jason L. Parsons	2024	5
4	In Vitro Low-Fluence Photodynamic Therapy Parameter Screening Using 3D Tumor Spheroids Shows that Fractionated Light Treatments Enhance Phototoxicity ACS Biomaterials Science & Engineering ·José Cosme, Thaddeus E. Mac Krell, Nicola Green, Helen E. Bryant, Frederik Claeyssens	2021	15
5	Magnetosomes and Magnetosome Mimics: Preparation, Cancer Cell Uptake and Functionalization for Future Cancer Therapies Pharmaceutics ·Haoyu Deng, T. Liu, G. Schmidt, S-J Chung, Andrea E. Rawlings, Helen E. Bryant, Munitta Muthana, Sarah S. Staniland	2021	12
6	PrimPol-dependent single-stranded gap formation mediates homologous recombination at bulky DNA adducts Nature Communications ·Ann Liza Piberger, K.S. Lee, Richard D. Kelly, Alexandra K. Walker, Daniel González‐Acosta, Laura J. Bailey, Aidan J. Doherty, Juan Méndez, Joanna R. Morris, Helen E. Bryant, Eva Petermann	2020	81
7	Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma EBioMedicine ·Sally L. George, Federica Lorenzi, David S. King, Sabine Hartlieb, James Campbell, Hugh Pemberton, Umut H. Toprak, Karen Barker, Su Bao, Barbara Martins Da Costa, Marlinde L. van den Boogaard, M. Emmy M. Dolman, Jan J. Molenaar, Helen E. Bryant, Frank Westermann, Christopher J. Lord, Louis Chesler	2020	47
8	Heteronuclear d–d and d–f Ru(ii)/M complexes [M = Gd(iii), Yb(iii), Nd(iii), Zn(ii) or Mn(ii)] of ligands combining phenanthroline and aminocarboxylate binding sites: combined relaxivity, cell imaging and photophysical studies Dalton Transactions ·Max Coale, Marlen S. Lapson, Dimitri Chekulaev, Luke K. McKenzie, Dang Chun-bo, Julia A. Weinstein, Anthony J. H. M. Meijer, Helen E. Bryant, Louise S. Natrajan, Adam W. Woodward, Michael D. Ward	2019	21
9	Carbon dot-protoporphyrin IX conjugates for improved drug delivery and bioimaging PLoS ONE ·José Cosme, Helen E. Bryant, Frederik Claeyssens	2019	28
10	Photophysical and Cellular Imaging Studies of Brightly Luminescent Osmium(II) Pyridyltriazole Complexes Inorganic Chemistry ·Torgomian Al, Paul A. Scattergood, Luke K. McKenzie, Dang Chun-bo, Nathan J. Patmore, Anthony J. H. M. Meijer, Julia A. Weinstein, Craig R. Rice, Helen E. Bryant, Paul I. P. Elliott	2018	24
11	Pyridazine-bridged cationic diiridium complexes as potential dual-mode bioimaging probes RSC Advances ·Ana Paula Franco de Andrade, Luke K. McKenzie, Jibo Sun, Julia A. Weinstein, Valery N. Kozhevnikov, Helen E. Bryant	2018	20
12	DNA damage repair in breast cancer and its therapeutic implications Pathology ·Reem Ali, Emad A. Rakha, Srinivasan Madhusudan, Helen E. Bryant	2016	54
13	Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11 Clinical Cancer Research ·Ross M. Drayton, Ewa Dudziec, Stefán Péter, Simone Bertz, Arndt Hartmann, Helen E. Bryant, James W.F. Catto	2014	189
14	Identification and Diagnostic Performance of a Small RNA within the PCA3 and BMCC1 Gene Locus That Potentially Targets mRNA Cancer Epidemiology Biomarkers & Prevention ·Ross M. Drayton, Ishtiaq Rehman, Raymond A. Clarke, Zhongming Zhao, Karl H. Pang, Saiful Miah, Robert Stoehr, Arndt Hartmann, SHOPULOTOV Shokhrukh Asliddinovich, Martin F. Lavin, Helen E. Bryant, Elena S. Martens‐Uzunova, Guido Jenster, Freddie C. Hamdy, Robert A. Gardiner, James W.F. Catto	2014	9
15	Resistance of uveal melanoma to the interstrand cross-linking agent mitomycin C is associated with reduced expression of CYP450R British Journal of Cancer ·Polly Gravells, J. Mierzejewski, David Cánovas, I G Rennie, Karen Sisley, Helen E. Bryant	2011	6
16	Atypically low spontaneous sister chromatid exchange formation in uveal melanoma Genes Chromosomes and Cancer ·J. Mierzejewski, Polly Gravells, David Cánovas, 邦彦鳴瀬, I G Rennie, Helen E. Bryant, Karen Sisley	2010	6
17	Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer Cancer Research ·James W.F. Catto, Saiful Miah, Helen C. Owen, Helen E. Bryant, Katie Myers, Ewa Dudziec, S. Larré, Marta Milo, Ishtiaq Rehman, Derek J. Rosario, Erica di Martino, Margaret A. Knowles, Mark Meuth, Adrian L. Harris, Freddie C. Hamdy	2009	272
18	Specific targeted gene repair using single-stranded DNA oligonucleotides at an endogenous locus in mammalian cells uses homologous recombination DNA repair ·Jennifer McLachlan, Serena Fernandez, Thomas Helleday, Helen E. Bryant	2009	8
19	Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Nature ·Helen E. Bryant, Niklas Schultz, Huw D. Thomas, E.-Marcel Prot, Ф. И. Стеблий, Elena López‐Knowles, Suzanne Kyle, Mark Meuth, Nicola J. Curtin, Thomas Helleday Hit paper breakdown →	2005	3780
20	The Multifunctional Herpes Simplex Virus IE63 Protein Interacts with Heterogeneous Ribonucleoprotein K and with Casein Kinase 2 Journal of Biological Chemistry ·Nagai Yasuyoshi, Helen E. Bryant, Odile Filhol, J. E. Scott, Tsai‐Yuan Hsieh, Roger D. Everett, J. Barklie Clements	1999	75

About Helen E. Bryant

Helen E. Bryant is a scholar working on Oncology, Cancer Research, Molecular Biology, Ophthalmology and Pulmonary and Respiratory Medicine, having authored 69 papers that have together received 8.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (28 papers), PARP inhibition in cancer therapy (21 papers), CRISPR and Genetic Engineering (8 papers), Photodynamic Therapy Research Studies (7 papers), Cancer therapeutics and mechanisms (5 papers), Nanoplatforms for cancer theranostics (5 papers), Lanthanide and Transition Metal Complexes (5 papers) and Neuroblastoma Research and Treatments (5 papers). The work is most often cited by research in Oncology (4.8k citations), Molecular Biology (5.5k citations), Cancer Research (1.2k citations), Reproductive Medicine (358 citations) and Genetics (825 citations). Helen E. Bryant has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Thomas Helleday, Niklas Schultz, Mark Meuth, Nicola J. Curtin, Huw D. Thomas, Elena López‐Knowles, Suzanne Kyle, Luke K. McKenzie, Julia A. Weinstein and Daniel Yeomanson. Their work appears in journals such as Oncotarget, DNA repair, Journal of Biological Chemistry, Nucleic Acids Research and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact